TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T06574 AS T26856. XX ID T06574 XX DT 11.07.2005 (created); ili. DT 25.09.2013 (updated); mkl. CO Copyright (C), QIAGEN. XX FA MAZ-isoform2 XX SY MAZ; MAZI; Myc-associated zinc finger protein; MYC-associated zinc finger protein (purine-binding transcription factor); Pur-1; Purine-binding transcription factor; SAF-2; Serum amyloid A-activating factor-1; Transcription factor Zif87; ZF87; Zinc finger protein 801; ZNF801. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002730 MAZ; HGNC: MAZ. XX CL C0001; CH. XX SZ 493 AA; 51.1 kDa (cDNA) (calc.). XX SQ MFPVFPCTLLAPPFPVLGLDSRGVGGLMNSFPPPQGHAQNPLQVGAELQSRFFASQGCAQ SQ SPFQAAPAPPPTPQAPAAEPLQVDLLPVLAAAQESAAAAAAAAAAAAAVAAAPPAPAAAS SQ TVDTAALKQPPAPPPPPPPVSAPAAEAAPPASAATIAAAAATAVVAPTSTVAVAPVASAL SQ EKKTKSKGPYICALCAKEFKNGYNLRRHEAIHTGAKAGRVPSGAMKMPTMVPLSLLSVPQ SQ LSGAGGGGGEAGAGGGAAAVAAGGVVTTTASGKRIRKNHACEMCGKAFRDVYHLNRHKLS SQ HSDEKPYQCPVCQQRFKRKDRMSYHVRSHDGAVHKPYNCSHCGKSFSRPDHLNSHVRQVH SQ STERPFKCEKCEAAFATKDRLRAHTVRHEEKVPCHVCGKMLSSAYISDHMKVHSQGPHHV SQ CELCNKGFTTAAYLRIHAVKDHGLQAPRADRILCKLCSVHCKTPAQLAGHMQTHLGGAAP SQ PVPGDAPQPQPTC XX SC Swiss-Prot#P56270-2 XX FT 59 421 PF00478; IMP dehydrogenase / GMP reductase domain. FT 73 73 MAPK phosphorylation site [1]. FT 91 112 poly-alanine tract (19/23) [1]. FT 130 139 poly-proline tract (9/19) [1]. FT 144 163 poly-alanine tract (113/20) [1]. FT 190 212 PF00096; zf-C2H2. FT 190 212 SM00355; c2h2final6. FT 190 217 PS50157; ZINC_FINGER_C2H2_2. FT 192 212 zinc finger 1 [1]. FT 279 301 PF00096; zf-C2H2. FT 279 301 SM00355; c2h2final6. FT 279 306 PS50157; ZINC_FINGER_C2H2_2. FT 281 301 zinc finger 2 [1]. FT 307 329 PF00096; zf-C2H2. FT 307 329 SM00355; c2h2final6. FT 307 334 PS50157; ZINC_FINGER_C2H2_2. FT 309 329 zinc finger 3 [1]. FT 337 360 PF00096; zf-C2H2. FT 337 360 SM00355; c2h2final6. FT 337 365 PS50157; ZINC_FINGER_C2H2_2. FT 339 360 zinc finger 4 [1]. FT 366 388 PF00096; zf-C2H2. FT 366 388 SM00355; c2h2final6. FT 366 393 PS50157; ZINC_FINGER_C2H2_2. FT 368 388 zinc finger 5 [1]. FT 392 413 SM00355; c2h2final6. FT 394 413 zinc finger 6 [1]. FT 419 442 PF00096; zf-C2H2. FT 419 442 SM00355; c2h2final6. FT 419 447 PS50157; ZINC_FINGER_C2H2_2. FT 421 442 zinc finger 7 [1]. FT 452 474 SM00355; c2h2final6. FT 454 474 zinc finger 8 [1]. XX SF considered to be an alternative spliced form of the MAZ gene [1]; SF other splice variant is T00490 [1]; SF contain 8 zinc fingers of the C2H2-type [1]; SF suggested to form dimers with SAF-1, another splice variant of the MAZ gene [1]; SF phosphorylated by MAP kinase in vitro [1]; XX FF level of transcript and protein decline during many inflammatory conditions [1]; FF its co-expression can considerably reduce the transactivation potential of MAZ/SAF-1 [1]; XX MX M07297 V$MAZ_Q5. MX M00649 V$MAZ_Q6. MX M02023 V$MAZ_Q6_01. XX BS R12104. XX DR TRANSPATH: MO000056182. DR EMBL: AF489858; AF489858. DR UniProtKB: P56270-2; MAZ_HUMAN. XX RN [1]; RE0035146. RX PUBMED: 12270922. RA Ray B. K., Murphy R., Ray P., Ray A. RT SAF-2, a splice variant of SAF-1, acts as a negative regulator of transcription. RL J. Biol. Chem. 277:46822-46830 (2002). XX //